NASDAQ: $KOD A Major Milestone in Eye Care Recent clinical news brings a promising update for patients suffering from wet age-related macular degeneration (wAMD). The pivotal Daybreak trial has officially met its primary endpoints for Zenkuda (tabirafusp-ted), marking a significant step forward in the development of new treatment options for this sight-threatening condition. Understanding the…